Account
Inquiry
Cagrilintide is a pharmaceutical peptide currently under development as a novel long-acting acylated amylin analogue. This investigational compound acts as a nonselective amylin receptor (AMYR) and calcitonin G protein-coupled receptor (CTR) agonist, showing significant potential for obesity research.
The peptide demonstrates remarkable effects in inducing weight loss and reducing food intake in clinical studies. Its mechanism of action makes it particularly interesting for metabolic disorder research and potential therapeutic applications.
This high purity Cagrilintide is supplied as a white to off-white powder with excellent stability when stored properly. The material undergoes rigorous quality control testing to ensure consistent performance in research applications.
As with all research peptides, this product is intended for laboratory use only by qualified professionals. It is not intended for human consumption or diagnostic use.
Researchers working in metabolic disorders, obesity mechanisms, or peptide therapeutics will find this high-quality Cagrilintide material valuable for their investigations.
